CTOs on the Move

Value Drug Company

www.valuedrugco.com

 
Value Drug Company, founded in 1934 and incorporated in 1936, is a wholesale purchasing cooperative of Independent Pharmacies.
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Doug Lockard
Director of IT Infrastructure Profile

Similar Companies

Saint Mary`s Healthcare

St. Mary`s Healthcare offers a continuum of services designed to fulfill the total healthcare needs of the community, while being the lowest cost provider. In addition to our 143 bed hospital, a 160 bed nursing home and a 10 bed acute rehabilitation unit, St. Mary`s provides highly accessible healthcare through its seven offsite primary care centers and behavioral health service locations throughout two counties. We treat more than 290,000 outpatient visits a year. Founded by the Sisters of St. Joseph of Carondelet in 1903, and as a member of Ascension since 2002, St. Mary`s is dedicated to improving the health of the community with special attention to the poor and underserved. By addressing the spiritual, social, emotional and physical needs of our patients, we strive to provide an exceptional patient experience and a model community for our associates and medical staff.

Nobest Inc

Nobest Inc is a Garden Grove, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Whip Mix Corp.

Whip Mix is the one resource that helps the Dental Profession achieve its goals of high quality, less invasive patient care, reduced chair time and increased operating efficiencies.

Lawall Orthotics and Prosthetics

Lawall Orthotics and Prosthetics is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heron Therapeutics

Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomerâ„¢ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.